KIN101

CAS No. 610753-87-2

KIN101( 3-(4-Bromophenyl)-7-[(methylsulfonyl)oxy]-4-oxo-4H-chromene )

Catalog No. M26270 CAS No. 610753-87-2

KIN101, an isoflavone agonist of IRF-3 dependent signaling, induces IRF-3 nuclear translocation. KIN101 has antiviral activity against RNA viruses, HCV, and RSV.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 29 In Stock
25MG 51 In Stock
50MG 84 In Stock
100MG 126 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    KIN101
  • Note
    Research use only, not for human use.
  • Brief Description
    KIN101, an isoflavone agonist of IRF-3 dependent signaling, induces IRF-3 nuclear translocation. KIN101 has antiviral activity against RNA viruses, HCV, and RSV.
  • Description
    KIN101, an isoflavone agonist of IRF-3 dependent signaling, induces IRF-3 nuclear translocation. KIN101 has antiviral activity against RNA viruses, HCV, and RSV.(In Vitro):KIN101 results in a significant increase in the levels of ISGs as well as other proteins downstream of IRF activation such as RIG-I and MDA5.KIN101 (10 μM; 24 hours) causes a significant decrease in the NP protein abundance. KIN 101 (10 μM; 18 hours) shows a >1 log decrease in HCV RNA levels. KIN 101 (5, 10, 20, 50 μM; 4 hours) causes a dose-dependent decrease in influenza virus infection in MRC5 cells. KIN101 (0.01, 0.1, 1, 10, 100 μM) has a significant and dose-dependent effect on the formation of foci and has an IC50 of 0.2 μM.
  • In Vitro
    KIN 101 (10 μM; 24 hours) causes a significant decrease in the NP protein abundance.KIN 101 (10 μM; 18 hours) shows a >1 log decrease in HCV RNA levels.KIN 101 (0.01, 0.1, 1, 10, 100 μM) has a significant and dose-dependent effect on the formation of foci and has an IC50 of 0.2 μM.KIN 101 (5, 10, 20, 50 μM; 4 hours) causes a dose-dependent decrease in influenza virus infection in MRC5 cells.KIN 101 results in a significant increase in the levels of ISGs as well as other proteins downstream of IRF activation such as RIG-I and MDA5.KIN101 (0.1-100 μM; 18 hours) shows the antiviral activity against hepatitis C virus (HCV). Western Blot Analysis Cell Line:MRC5 cells Concentration:10 μM Incubation Time:24 hours Result:Caused a significant decrease in the NP protein abundance. RT-PCR Cell Line:Huh7 cells Concentration:10 μM Incubation Time:18 hours Result:Showed a >1 log decrease in HCV RNA levels.
  • In Vivo
    ——
  • Synonyms
    3-(4-Bromophenyl)-7-[(methylsulfonyl)oxy]-4-oxo-4H-chromene
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    NMDA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    610753-87-2
  • Formula Weight
    395.22
  • Molecular Formula
    C16H11BrO5S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 41.67 mg/mL (105.43 mM)
  • SMILES
    CS(=O)(=O)Oc1ccc2c(c1)occ(-c1ccc(Br)cc1)c2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Parsons CG, et al. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization. Journal of Pharmacology and Experimental Therapeutics (1997), 283(3), 1264-1275
molnova catalog
related products
  • BLT-1

    BLT-1 is a scavenger receptor BI (SR-BI)inhibitor.BLT-1 has IC50s of 60 and 110 nM for cellular DiI-HDL and [3H]CE-HDL uptake in ldlA[mSR-BI] cells.

  • Narirutin

    Narirutin has anti-allergic and anti-inflammatory properties, can reduce airway inflammation in ovalbumin (OVA)-sensitized / challenged NC / Nga mice, a model of allergic eosinophilic airway inflammation.

  • Simeprevir

    A potent, orally available inhibitor of HCV NS3/4A protease with Ki of 0.36 nM, replicon EC50 of 7.8 nM.